New research published in the journal Cell reveals that severe COVID-19 cases are often linked to a pre-existing immune defect where the body produces autoantibodies that neutralize type I interferons. According to findings from an international team of scientists, these autoantibodies are the result of a mature B-cell response that disables the body’s primary antiviral … Read more
Breakthrough in Oral Cancer Research: New Immune Pathway Could Revolutionize Early Intervention Researchers at The University of Texas MD Anderson Cancer Center have uncovered a critical immune pathway linked to the progression of oral precancerous lesions into head and neck squamous cell carcinoma, offering a potential roadmap for early intervention. The findings, published in *Cancer … Read more
Stanford Medicine researchers have identified a primary driver of biological aging: the failure of tissue-resident macrophages to clear senescent, or “zombie,” neutrophils from the body. According to a study published July 16 in Science, blocking a specific pro-inflammatory receptor, EP2, on these immune cells rejuvenated organ function and reduced age-related frailty in mice. This discovery … Read more
Senescent cells—damaged cells that stop dividing but remain metabolically active—accumulate lipid droplets as a hallmark of their aging state, according to a study published July 1, 2026, in the journal Aging. Researchers led by Noa Rachmian-Cooper and Valery Krizhanovsky at the Weizmann Institute of Science found that these lipid deposits are linked to chronic inflammation … Read more
Lactoferrin-fortified yogurt maintains ferritin levels in pregnant women with gestational diabetes mellitus (GDM) without causing iron overload, according to a randomized trial published in npj Science of Food. The study found that 100 mg of bovine lactoferrin per serving helped stabilize iron stores in women with reduced ferritin, offering a well-tolerated alternative to relying solely … Read more
Hepatocellular carcinoma (HCC) is currently the third leading cause of cancer death, with patient outcomes hindered by late diagnosis and scarce early biomarkers. According to a 2026 review in the journal Gene Expression, advancements in multi-omics and liquid biopsy are shifting the clinical landscape by enabling more precise prognostic tracking and personalized immunotherapy selection, though … Read more
Researchers at VCU Massey Comprehensive Cancer Center have developed an experimental molecule called an autophagy-targeting chimera (AUTAC) that dismantles the MCL1 survival protein to kill multiple myeloma cells. According to a study published in Cell Death & Disease, this targeted protein degrader works with existing proteasome inhibitors to reduce cancer cell viability by 50% within … Read more
Bioengineers at the University of California San Diego have created the first genome-scale reference map detailing how individual genes influence the behavior and identity of human induced pluripotent stem cells (iPSCs). Published in Nature Biotechnology, the study utilized CRISPR technology to systematically switch off 11,692 genes, providing a reference atlas for researchers to predict how … Read more
Researchers at The University of Texas MD Anderson Cancer Center have identified that resistance to tagraxofusp in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) is driven by severe mutations in the TET2 gene and reduced expression of the TXNRD1 enzyme. Published in the journal Leukemia, the study provides a potential framework for using these … Read more
Researchers have identified a new chemical compound, DE19725241, that shows potential in targeting the fat mass and obesity-associated protein (FTO) to treat pancreatic cancer. According to a study published in BIO Integration, the compound demonstrated selective antiproliferative activity in pancreatic cancer cell lines by binding to specific protein sites, offering a potential new scaffold for … Read more